Drugs / Invivac®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00345462 | Jun 2006 → ? | — | Solvay Pharmaceuticals | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Invivac | “The current study is a phase IIIa clinical trial with a commercially available virosomal vaccine (Invivac®) supplied in pre filled syringes.” NCT00345462 ↗ |
| Modality | Vaccine | “commercially available virosomal vaccine (Invivac®)” NCT00345462 ↗ |